top of page
< Back

Mifamurtide

米伐木肽

Mechanism of action:

Mifamurtide 是一種胞壁醯三肽(muramyl tripeptide)類似物的脂質化衍生物。Mifamurtide 會被吞噬細胞(如巨噬細胞,macrophage)攝入並結合到 NOD2(nucleotide-binding oligomerization domain 2)受體,隨後會啟動 NF-κB、AP-1 等免疫相關調控路徑,增強巨噬細胞與嗜中性球的活性。

​Reference(s):

1. Ando K et al. (2011). Mifamurtide for the treatment of nonmetastatic osteosarcoma. Expert Opin Pharmacother. 


2. Kager L et al. (2010). Review of mifamurtide in the treatment of patients with osteosarcoma. Ther Clin Risk Manag.

bottom of page